@uncle joe / @caredes,
Upon reading your post/s again, a little thought bubble came to mind.
* on the assumption that a production run $900k worth of chips / wafers is imminent;
* that this run shows an acceptable level of failures;
* that AKP endorses the production of a further and larger quantity of wafers / chips;
* knowing that AKP traditionally likes to run off the whiff of an oily rag;
* noting Earth Mountain (Suzhou) Microelectronics' (EM) difficulties in obtaining approval to take 308,325 ordinary shares at $14.000 per share ($4,316,550) as part of the placement announced 24 August 2022;
AKP will need to raise monies to fund the first commercial qty production run of audio pixels.
I surmise that a back door way could be for AKP to fund this transaction (in kind) via the issue of AKP stock.
AKP already have approval for the issue / granting of 308,325 shares to EM.
Surely at the next AGM (predicted by some posters on this forum to be in August 2024) could see approval being sought (by AKP) to grant EM a larger stake in the company in consideration of the manufacture of part / all of this production run (providing an acceptable level of failures in this run).
This provides AKP with funds in kind for its largest forward moving cost (the first commercial production run of its product), whilst at the same time precludes the need for EM to seek approval from the required China regulatory authorities to approve EM’s foreign investment (given that no funds are leaving China).
All supposition from my part. I have no knowledge of such a transaction or in fact if this is even on the cards / possible.
Dyor and Gltah.
- Forums
- ASX - By Stock
- AKP
- Ann: Continued Suspension from Quotation
Ann: Continued Suspension from Quotation, page-438
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.20 |
Change
0.000(0.00%) |
Mkt cap ! $181.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AKP (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online